Publications by authors named "Enea M"

Gold nanoparticles (AuNPs) are highly attractive for applications in the field of biosensing, particularly for colorimetric nucleic acid detection. Their unique optical properties, which are highly sensitive to changes in their environment, make them ideal candidates for developing simple, rapid, and cost-effective assays. When functionalized with oligonucleotides (Au-nanoprobes), they can undergo aggregation or dispersion in the presence of complementary sequences, leading to distinct color changes that serve as a visual signal for detection.

View Article and Find Full Text PDF
Article Synopsis
  • This study examines how early clinical hepatic decompensation (CHD) affects the overall survival (OS) of patients with unresectable hepatocellular carcinoma (uHCC) who are receiving systemic treatments like Atezolizumab plus Bevacizumab or Sorafenib.
  • Researchers analyzed data from the IMbrave150 trial and found that patients experiencing early CHD had a significantly higher risk of mortality, indicating a poor prognosis.
  • The study identifies specific factors (like ALBI grade, INR levels, and macrovascular invasion) that put patients at a greater risk for CHD, suggesting that these could be useful in future clinical trials to better assess patient outcomes.
View Article and Find Full Text PDF

Background: Multiple factors can fuel nurses' intention to leave their employing hospital or their profession. Job dissatisfaction and burnout are contributors to this decision. Sociodemographic and work context factors can also play a role in explaining nurses' intention to leave.

View Article and Find Full Text PDF

Background And Aims: Patients with overt or occult hepatitis B virus (HBV) infection receiving immunosuppressive treatments have a wide risk of HBV reactivation (HBVr). We performed meta-analysis with decision curve analyses (DCA) to estimate the risk of HBVr in HBsAg-negative anti-HBc-positive patients naïve to nucleos(t)ide analogues (NAs) receiving immunosuppressive treatments.

Approach And Results: Studies were identified through literature search until October 2022.

View Article and Find Full Text PDF

Importance: The recent change in terminology from nonalcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) highlights the link between hepatic steatosis and metabolic dysfunction, taking out the stigmata of alcohol.

Objective: We compared the effects of NAFLD and MAFLD definitions on the risk of overall and cardiovascular (CV) mortality, liver-related events (LRE), nonfatal CV events (CVE), chronic kidney disease (CKD), and extra-hepatic cancers (EHC).

Data Sources And Study Selection: We systematically searched four large electronic databases for cohort studies (published through August 2023) that simultaneously used NAFLD and MAFLD definitions for examining the risk of mortality and adverse CV, renal, or oncological outcomes associated with both definitions.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the impact of hepatic functional reserve and tumor progression on overall survival in patients with hepatocellular carcinoma (HCC) undergoing combination immunotherapy with atezolizumab and bevacizumab.
  • Out of 571 patients analyzed, a significant portion developed tumor progression, while a smaller group experienced hepatic decompensation, both of which greatly affected survival outcomes.
  • Key predictors of poor survival included hepatic decompensation, advanced tumor progression, and specific baseline liver function metrics, with effective antiviral treatment showing potential protective effects against decompensation in patients with viral causes of HCC.
View Article and Find Full Text PDF
Article Synopsis
  • Atezolizumab + bevacizumab is currently the leading treatment for advanced hepatocellular carcinoma (HCC), but there's limited direct comparison with other therapies like immune checkpoint inhibitors (ICIs) combined with tyrosine kinase inhibitors (TKIs).
  • A network meta-analysis assessed various first-line systemic therapies, examining their efficacy in terms of overall survival (OS) and progression-free survival (PFS), while also considering safety profiles.
  • The analysis included nine studies with 6,600 patients, finding that atezolizumab plus bevacizumab had the highest probabilities for 30-month OS, while lenvatinib excelled in PFS; ICI monotherapies were the most tolerable, and the net health
View Article and Find Full Text PDF

Gold nanoparticles (AuNPs) exhibit improved optical and spectral properties compared to bulk materials, making them suitable for the detection of DNA, RNA, antigens, and antibodies. Here, we describe a simple, selective, and rapid non-cross linking detection assay, using approx. 35 nm spherical Au nanoprobes, for a common mutation occurring in exon 19 of the epidermal growth factor receptor (EGFR), associated with non-small-cell lung cancer cells.

View Article and Find Full Text PDF

The European healthcare sector faces a significant shortage of healthcare workers. Assessing the prevalence of this issue and understanding its direct and indirect determinants are essential for formulating effective recruitment programs and enhancing job retention strategies for physicians and nurses. A multicentric cross-sectional study was conducted, involving 381 physicians and 1351 nurses recruited from eight European hospitals in Belgium, the Netherlands, Italy, and Poland.

View Article and Find Full Text PDF

Background And Aims: International regulatory agencies recommend testing drug therapy for patients with noncirrhotic high-risk metabolic dysfunction-associated steatohepatitis (MASH) because they are at risk of liver-related events (LRE). We aimed to compare the risk of LRE in patients with MASLD stratified for F2-F4 fibrosis and MASH.

Approach And Results: Overall, 1938 consecutive patients with biopsy-proven MASLD were enrolled.

View Article and Find Full Text PDF

Background & Aims: We aimed to evaluate the impact of oesophageal varices (OV) and their evolution on the risk of complications of compensated advanced chronic liver disease (cACLD) caused by non-alcoholic fatty liver disease (NAFLD). We also assessed the accuracy of non-invasive scores for predicting the development of complications and for identifying patients at low risk of high-risk OV.

Methods: We performed a retrospective assessment of 629 patients with NAFLD-related cACLD who had baseline and follow-up oesophagogastroduodenoscopy and clinical follow-up to record decompensation, portal vein thrombosis (PVT), and hepatocellular carcinoma.

View Article and Find Full Text PDF

Serological screening and seroprevalence data for TORCH infections represent a key instrument to estimate immunity and vaccination levels and exposure rates to prevent and treat TORCH congenital infections. Serology allows us to identify women susceptible to primary infection. Assess the prevalence of women at risk of primary infections by TORCH pathogens in Palermo, Sicily, Italy, in the decade 2012-2022.

View Article and Find Full Text PDF

Background And Aims: Programmed cell death 1/programmed cell death-ligand 1 (PD-1/PDL-1) axis has been reported to modulate liver inflammation and progression to hepatocellular carcinoma (HCC) in patients with nonalcoholic fatty liver disease (NAFLD). Here, we examined whether the PDCD1 variation is associated with NAFLD severity in individuals with liver biopsy.

Methods: We examined the impact of PDCD1 gene variants on HCC, as robust severe liver disease phenotype in UK Biobank participants.

View Article and Find Full Text PDF
Article Synopsis
  • * Findings showed that liver stiffness measurement (LSM) and AGILE 3+ tests were superior to traditional serum-based tests (like FIB-4 and NAFLD Fibrosis Score) for identifying advanced fibrosis and fibrotic NASH, while also reducing the number of necessary invasive tests.
  • * The study concluded that combining LSM and AGILE 3+ tests, particularly in low resource settings, provides reliable diagnostic accuracy for advanced
View Article and Find Full Text PDF

Background: Though the precise criteria for accessing LT are consistently being applied, HCC recurrence (HCC-R_LT) still affects more than 15% of the patients. We analyzed the clinical, histopathological, and biological features of patients with HCC to identify the predictive factors associated with cancer recurrence and survival after LT.

Methods: We retrospectively analyzed 441 patients with HCC who underwent LT in our center.

View Article and Find Full Text PDF

Introduction: Noninvasive criteria to predict the progression of low-risk esophageal varices (EV) in patients with compensated hepatitis C virus (HCV) cirrhosis after sustained virological response (SVR) by direct-acting antivirals (DAAs) are lacking. Our aim was to assess the diagnostic performance of Rete Sicilia Selezione Terapia-HCV (RESIST-HCV) criteria for EV progression compared with elastography-based criteria (Baveno VI, Expanded Baveno VI, and Baveno VII-HCV criteria).

Methods: All consecutive patients observed at 3 referral centers with compensated HCV cirrhosis with or without F1 EV who achieved sustained virological response by DAAs were classified at last esophagogastroduodenoscopy (EGDS) as RESIST-HCV low risk (i.

View Article and Find Full Text PDF

Background: The aims of this study were to quantify the histological improvement and its risk factors in patients with NASH enrolled in the placebo arms of randomized controlled trials (RCTs), and to indirectly compare the effect of several investigational drugs for NASH on validated histological outcomes.

Data Synthesis: A comprehensive search was conducted to detect phase 2 and 3 RCTs comparing pharmacological interventions in patients with NASH. According to Food and Drug Administration (FDA) recommendations, primary outcomes included: 1) NASH resolution without worsening of fibrosis; 2) At least 1-point reduction in fibrosis without worsening of NASH.

View Article and Find Full Text PDF

Background And Aims: Implantation of a transjugular intrahepatic portosystemic shunt (TIPS) improves survival in patients with cirrhosis with refractory ascites and portal hypertensive bleeding. However, the indication for TIPS in older adult patients (greater than or equal to 70 years) is debated, and a specific prediction model developed in this particular setting is lacking. The aim of this study was to develop and validate a multivariable model for an accurate prediction of mortality in older adults.

View Article and Find Full Text PDF

This work investigates quasi-static crack propagation in specimens made of brittle materials by combining local and non-local elasticity models. The portion of the domain where the failure initiates and then propagates is modeled via three-dimensional bond-based peridynamics (PD). On the other hand, the remaining regions of the structure are analyzed with high order one-dimensional finite elements based on the Carrera unified formulation (CUF).

View Article and Find Full Text PDF